Skip to Main Content

Author Details

Luis Martinez-Sobrido
Texas Biomedical Research Institute
2001
349
63
Kirsten Obernier (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37990641Extracellular Delivery of Functional Mitochondria Rescues the Dysfunction of CD4<sup>+</sup> T Cells in Aging.Adv Sci (Weinh)2024
34159337Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects.bioRxiv2023
37750714Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis <i>in vivo</i>.Antimicrob Agents Chemother2023
37515226Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody.Viruses2023
37581931Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects.J Clin Invest2023
37651466A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo.PLoS Pathog2023
37738983Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.Cell Host Microbe2023
37738970SARS-CoV-2 variants evolve convergent strategies to remodel the host response.Cell2023
37090670Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis <i>in vivo</i>.bioRxiv2023
37191507Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission.Microbiol Spectr2023
37288969A new tractable method for generating human alveolar macrophage-like cells <i>in vitro</i> to study lung inflammatory processes and diseases.mBio2023
37318331Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies.Microbiol Spectr2023
37187533The IFN-stimulated gene IFI27 counteracts innate immune responses after viral infections by interfering with RIG-I signaling.Front Microbiol2023
36989354Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors.Sci Adv2023
37345956SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication.mBio2023
37115795Glucuronoxylomannan intranasal challenge prior to Cryptococcus neoformans pulmonary infection enhances cerebral cryptococcosis in rodents.PLoS Pathog2023
37311533Aerosolized sulfated hyaluronan derivatives prolong the survival of K18 ACE2 mice infected with a lethal dose of SARS-CoV-2.Eur J Pharm Sci2023
37278625Identification of <i>In Vitro</i> Inhibitors of Monkeypox Replication.Microbiol Spectr2023
37243110Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models.Vaccines (Basel)2023
37131711A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication and pathogenesis <i>in vivo</i>.bioRxiv2023
37131608Antivirals against monkeypox infections.bioRxiv2023
37163142Mitigation of SARS-CoV-2 by Using Transition Metal Nanozeolites and Quaternary Ammonium Compounds as Antiviral Agents in Suspensions and Soft Fabric Materials.Int J Nanomedicine2023
37066199A new tractable method for generating Human Alveolar Macrophage Like cells in vitro to study lung inflammatory processes and diseases.bioRxiv2023
36656900Clinical and pathological characterization of Central Nervous System cryptococcosis in an experimental mouse model of stereotaxic intracerebral infection.PLoS Negl Trop Dis2023
36786559Phospholipase B Is Critical for Cryptococcus neoformans Survival in the Central Nervous System.mBio2023
36810517Antibodies, B Cell Responses and Immune Responses to SARS-CoV-2 Infections.Antibodies (Basel)2023
36580912SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming.Cell2023
36710070Methamphetamine induces a low dopamine transporter expressing state without altering the total number of peripheral immune cells.Basic Clin Pharmacol Toxicol2023
36533953Molecular Engineering of a Mammarenavirus with Unbreachable Attenuation.J Virol2023
36942851Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses.Elife2023
36894533Circadian clock molecule REV-ERBα regulates lung fibrotic progression through collagen stabilization.Nat Commun2023
36793726Interferon alpha inducible protein 6 is a negative regulator of innate immune responses by modulating RIG-I activation.Front Immunol2023
36698765CoDe: a web-based tool for codon deoptimization.Bioinform Adv2023
36194133SARS-CoV-2 3CL<sup>pro</sup> mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376.Sci Transl Med2023
34668775The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.J Virol2022
35738348Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies.Antiviral Res2022
35583364Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine.Microbiol Spectr2022
35583360Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development.Microbiol Spectr2022
35821477Generation, Characterization, and Applications of Influenza A Reporter Viruses.Methods Mol Biol2022
35821476Bioluminescent and Fluorescent Reporter-Expressing Recombinant SARS-CoV-2.Methods Mol Biol2022
35821475Generation of Bi-Reporter-Expressing Tri-Segmented Arenavirus.Methods Mol Biol2022
35817128Dung biomass smoke exposure impairs resolution of inflammatory responses to influenza infection.Toxicol Appl Pharmacol2022
35862475Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody.PLoS Pathog2022
35554912Animal Models of COVID-19: Transgenic Mouse Model.Methods Mol Biol2022
35357221Methamphetamine Enhances Cryptococcus neoformans Melanization, Antifungal Resistance, and Pathogenesis in a Murine Model of Drug Administration and Systemic Infection.Infect Immun2022
36342302Use of a Bacterial Artificial Chromosome to Generate Recombinant SARS-CoV-2 Expressing Robust Levels of Reporter Genes.Microbiol Spectr2022
36146823Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics.Viruses2022
36145467Intranasal Immunization with Liposome-Displayed Receptor-Binding Domain Induces Mucosal Immunity and Protection against SARS-CoV-2.Pathogens2022
36106872Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza Virus.J Virol2022
35937688Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use.Front Cell Infect Microbiol2022
  • 1 - 50 of 349

Recommended Authors

Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 32
Institut Pasteur, Center for the Viral Populations and Pathogenesis
Career Start Year 2017
Number of shared co-authors 30
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2015
Number of shared co-authors 38
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 16
Duke University School of Medicine
Career Start Year 2012
Number of shared co-authors 7
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 4
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 32
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 9
University of Texas Medical Branch
Career Start Year 2010
Number of shared co-authors 9
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 9
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 25
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 9
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 11
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 11
Biodesign Center for Fundamental and Applied Microbiomics, Arizona State University
Career Start Year 2007
Number of shared co-authors 4
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 19
NYU Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 9
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 8
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 13
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 6
The University of North Carolina at Chapel Hill
Career Start Year 1998
Number of shared co-authors 7
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 15
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 16
Washington University School of Medicine
Career Start Year 1996
Number of shared co-authors 9
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 11
University College London
Career Start Year 1992
Number of shared co-authors 29
University of Manitoba
Career Start Year 1991
Number of shared co-authors 7
University of North Carolina at Chapel Hill.
Career Start Year 1990
Number of shared co-authors 16
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 12
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 31

Collaborators

Texas Biomedical Research Institute
Co-authored papers 51
Icahn School of Medicine at Mount Sinai
Co-authored papers 48
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 19
Icahn School of Medicine at Mount Sinai
Co-authored papers 8
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Co-authored papers 7
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Texas Biomedical Research Institute
Co-authored papers 5
University of Washington Medical Center
Co-authored papers 5
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
University of Rochester Medical Center
Co-authored papers 5
University of California San Francisco
Co-authored papers 4
Icahn School of Medicine at Mount Sinai New York
Co-authored papers 4
Co-authored papers 4
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 4
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
University of Alabama at Birmingham Birmingham
Co-authored papers 3
University of Texas Health San Antonio
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Co-authored papers 3
Stanford University School of Medicine
Co-authored papers 3
The Ohio State University Wexner Medical Center
Co-authored papers 3
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 3
Drukier Institute for Children's Health
Co-authored papers 3
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 2
Co-authored papers 2
Regeneron Pharmaceuticals
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Gladstone Institutes
Co-authored papers 2
The Scripps Research Institute
Co-authored papers 2